Patents by Inventor Luis Felipe Vejarano Restrepo

Luis Felipe Vejarano Restrepo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPHTHALMIC FORMULATION AND METHOD FOR AMELIORATING PRESBYOPIA
    Publication number: 20200237916
    Abstract: An ophthalmic formulation having an effective amount of a parasympathomimetic agent comprising pilocarpine, or a pharmaceutically acceptable salt thereof, and one or more ?1 adrenergic agonists or antagonists is disclosed. The ophthalmic formulation may enable treatment of conditions adversely affecting the visual acuity of a patient, including presbyopia. A method of using the disclosed ophthalmic formulation to treat or ameliorate symptoms of presbyopia is also disclosed.
    Type: Application
    Filed: December 3, 2019
    Publication date: July 30, 2020
    Inventor: Luis Felipe Vejarano Restrepo
  • Ophthalmic formulation and method for ameliorating presbyopia
    Patent number: 10507245
    Abstract: An ophthalmic formulation having an effective amount of a parasympathomimetic agent comprising pilocarpine, or a pharmaceutically acceptable salt thereof, and one or more ?1 adrenergic agonists or antagonists is disclosed. The ophthalmic formulation may enable treatment of conditions adversely affecting the visual acuity of a patient, including presbyopia. A method of using the disclosed ophthalmic formulation to treat or ameliorate symptoms of presbyopia is also disclosed.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: December 17, 2019
    Inventor: Luis Felipe Vejarano Restrepo
  • OPHTHALMIC FORMULATION AND METHOD FOR AMELIORATING PRESBYOPIA
    Publication number: 20140024642
    Abstract: An ophthalmic formulation having an effective amount of a parasympathomimetic agent comprising pilocarpine, or a pharmaceutically acceptable salt thereof, and one or more ?1 adrenergic agonists or antagonists is disclosed. The ophthalmic formulation may enable treatment of conditions adversely affecting the visual acuity of a patient, including presbyopia. A method of using the disclosed ophthalmic formulation to treat or ameliorate symptoms of presbyopia is also disclosed.
    Type: Application
    Filed: July 19, 2012
    Publication date: January 23, 2014
    Inventor: Luis Felipe Vejarano Restrepo